Sort
1,049,261 grants matching “t cell”
GENERAL CLINICAL RESEARCH CENTER
$4,783,061New York University School Of Medicine · M01 · FY2003 · RR
Project 2: Vaccine Design Epidemic Flaviviruses
$4,782,234Aravinda M De Silva · Washington University · U19 · FY2024 · AI
Mechanisms, modeling and therapies of retinal and macular neurodegeneration
$4,780,891Anand Swaroop · National Eye Institute · ZIA · FY2025 · EY
Biospecimen Core
$4,779,434Bharat Thyagarajan · Washington University · U19 · FY2021 · AG
Pharmacokinetics and Drug Metabolism
$4,779,148Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
THE OVERALL PROJECT GOAL IS TO ADVANCE GORE’S ULTRA-THIN DIAPHRAGMS FROM TECHNOLOGY READINESS LEVEL (TRL) 3 TO TRL 5 IN SERVICE OF TWO PRIMARY OBJECTIVES: 1) TO MEET OR EXCEED DOE’S NEXT-GENERATION LIQUID ALKALINE WATER ELECTROLYZER (LAWE) PERFORMANCE TARGETS (2 A/CM2 AT = 1.7 V WITH = 2.1 MV/KH DEGRADATION) BY OPTIMIZING ULTRA-THIN DIAPHRAGMS AND PAIRING THEM WITH STATE-OF-THE-ART ELECTRODES, AND 2) TO DE-RISK THE ULTRA-THIN DIAPHRAGMS FOR SCALE-UP AT GORE TO ESTABLISH A DOMESTIC SUPPLY CHAIN OF ADVANCED LAWE SEPARATORS. EXPECTED OUTCOMES ARE: • PILOT-SCALE ROLLS OF ULTRA-THIN DIAPHRAGMS WITH OPTIMIZED STRUCTURE AND COMPOSITION, • DEEPER UNDERSTANDING OF DIAPHRAGM PROPERTY-STRUCTURE-PROPERTY-PERFORMANCE RELATIONSHIPS, • DATA FROM SINGLE CELLS AND A SMALL STACK DEMONSTRATING THAT DOE TARGETS HAVE BEEN MET, • A TECHNOECONOMIC ANALYSIS OF NEW DIAPHRAGMS ON LAWE STACK CAPITAL AND OPERATING COSTS, • COLLABORATIVE RELATIONSHIPS AMONG INDUSTRY LEADERS TO COMMERCIALIZE NEW LAWE TECHNOLOGY, AND • A MORE DIVERSE AND WELL-TRAINED WORKFORCE, MORE CAPABLE FACILITIES, AND MORE INVOLVED COMMUNITY
$4,779,120Wl Gore & Associates Inc · · FY2025 · Department of Energy
SINGLE CELL ANALYSIS FOR FORENSIC EPIGENETICS (SAFE)
$4,778,942Salk Institute For Biological Studies, San Diego, California, The · · FY2019 · Department of the Army
NOVEL THERAPEUTICS FOR PRION DISEASES
$4,778,184University Of California San Francisco · P01 · FY2004 · AG
Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity (IMPACT-CETR)
$4,776,780Richard Malley · Boston Children'S Hospital · U19 · FY2025 · AI
Fine Mapping and Functional Evaluation of Selected Type 1 Diabetes Loci
$4,773,945Hakon Hakonarson · Children'S Hosp Of Philadelphia · DP3 · FY2009 · DK
IGF::OT::IGF FRAMINGHAM HEART STUDY (FHS) - TASK ORDER 01
$4,772,193Vasan Ramachandran · Boston University Medical Campus · N01 · FY2016 · HL
Studies of Inherited Causes of Fungal Susceptability
$4,772,016Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Southwest Health Equity Research Collaborative
$4,771,697Julie Ann Baldwin · Northern Arizona University · U54 · FY2017 · MD
First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody
$4,770,702Andrew B Norman · University Of Cincinnati · U01 · FY2019 · DA
Alzheimer's Disease Research Centers
$4,770,384Helena Chang Chui · University Of Southern California · P30 · FY2025 · AG
Systems Approach to Innate Immunity-Inflammation-Sepsis
$4,769,797Scripps Research Institute · U54 · FY2003 · AI
Proteomics core
$4,769,065Danielle L Swaney · University Of California, San Francisco · U19 · FY2022 · AI
SOUTHERN RESEARCH MOLECULAR LIBRARIES SCREENING CENTER (SRMLSC)(RMI)
$4,768,215Gary A Piazza · Southern Research Institute · U54 · FY2007 · HG
Structural Bioinformatics Information Resources
$4,766,549Stephen H. Bryant · National Library Of Medicine · Z01 · FY2007 · LM
Functional Genomics of Maize Gametophytes
$4,765,932Matthew M Evans · Carnegie Institution Of Washington · · FY2007 · BIO
Spatial navigation, sex hormones, and the aging brain
$4,765,698Emily G Jacobs · University Of California Santa Barbara · RF1 · FY2025 · AG
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,764,161Yong-Jun Liu · Baylor Research Institute · U19 · FY2011 · AI
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies
$4,761,592Thomas T Perls · Boston University Medical Campus · UH2 · FY2019 · AG
Yale Alzheimer Disease Research Center
$4,760,911Stephen M Strittmatter · Yale University · P30 · FY2025 · AG
Integrative Multi-Omic Discovery of Proximal Mechanisms Driving Age-Dependent Neurodegeneration
$4,760,794Mel B Feany · Brigham And Women'S Hospital · RF1 · FY2017 · AG